History of SRNA and Advances in Rare Neuroimmune Disorders

home / roundtable-discussions / history-srna-and-advances-in-rare-neuroimmune-disorders

Sanford Siegel, Douglas Kerr, MD; and Benjamin Greenberg, MD, comment on several topics related to the treatment of rare neuroimmune disorders, including complexities with distinguishing certain conditions and where research should be dedicated to in the coming years.

© 2024 MJH Life Sciences

All rights reserved.